Several studies on its immunoexpression have demonstrated an association with biological aggressiveness [10, 12, 14–17, 22], since P-cadherin is frequently overexpressed in high-grade tumors being considered as a marker of poor prognosis in human breast cancer [12, 17, 23]. The gene discussed is CDH3; the disease is breast cancer.